Price
1,633
-0.43%52W Range
Market Cap
₹81,587.10 Cr
Traded: ₹50.04 Cr (0.06%) 0.0x
Free Float: ₹5,629.51 Cr (0.89% of FF traded)
Volume · 60D trend
3.06 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +16.0% | +17.0% | +15.0% | -- | +12.0% | Decelerating |
| ROE | +18.0% | +17.0% | +17.0% | -- | -- | Stable |
| Return | -- | +4.0% | +10.0% | -9.0% | -- | Stable |
| Profit | +18.0% | +12.0% | +14.0% | -- | -9.0% | Stable |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Sep 2026PDF ↗ | Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8,220 | 7,088 | 6,825 | 6,905 | 6,869 | 6,396 | 6,051 | 6,161 | 6,147 | 5,601 | 5,391 | 5,194 | 5,271 | 4,716 | 4,519 |
| Expenses | 7,005 | 6,566 | 6,138 | 6,051 | 5,825 | 5,415 | 5,443 | 5,199 | 5,207 | 4,831 | 4,701 | 4,639 | 4,509 | 4,206 | 4,874 |
| Operating Profit | 1,215 | 522 | 686 | 854 | 1,044 | 981 | 609 | 962 | 940 | 770 | 690 | 555 | 762 | 510 | -355 |
| Other Income | 32 | 14 | 32 | 16 | 33 | 13 | 60 | -2 | -21 | 4 | 8 | 19 | 2 | 10 | 928 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1,247 | 536 | 718 | 870 | 1,077 | 994 | 668 | 960 | 919 | 774 | 698 | 574 | 764 | 520 | 573 |
| Tax % | 24.0% | 25.0% | 24.0% | 24.0% | 24.0% | 25.0% | 24.0% | 25.0% | 24.0% | 25.0% | 26.0% | 25.0% | 24.0% | 25.0% | 24.0% |
| Net Profit | 946 | 403 | 547 | 659 | 820 | 747 | 510 | 724 | 694 | 580 | 520 | 431 | 577 | 390 | 437 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 18.9 | 8.1 | 11.0 | 13.2 | 16.5 | 15.0 | 10.3 | 14.6 | 14.0 | 11.8 | 10.5 | 8.8 | 11.8 | 8.0 | 8.9 |
| Sales Growth (YoY) | 19.7% | 10.8% | 12.8% | 12.1% | 11.8% | 14.2% | 12.2% | 18.6% | 16.6% | 18.8% | 19.3% | 13.9% | 12.9% | -- | -- |
| Sales Growth (QoQ) | -- | 3.9% | -1.2% | 0.5% | 7.4% | 5.7% | -1.8% | 0.2% | 9.8% | 3.9% | 3.8% | -1.5% | 11.8% | 4.4% | -- |
| OP Growth (YoY) | 16.4% | -46.8% | 12.6% | -11.2% | 11.1% | 27.4% | -11.7% | 73.3% | 23.4% | 51.0% | 294.4% | -- | -- | -- | -- |
| OP Growth (QoQ) | 132.8% | -23.9% | -19.7% | -18.2% | 6.4% | 61.1% | -36.7% | 2.3% | 22.1% | 11.6% | 24.3% | -27.2% | 49.4% | 243.7% | -- |
| Profit Growth (YoY) | 15.0% | -46.0% | 7.0% | -9.0% | 18.0% | 29.0% | -2.0% | 68.0% | 20.0% | 49.0% | 19.0% | 22.0% | -2.0% | 12.0% | 40.0% |
| EPS Growth (YoY) | -- | -46.3% | 6.6% | -9.6% | 17.4% | 27.8% | -2.5% | 67.0% | 19.4% | 48.0% | 18.4% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -26.3% | -17.2% | -19.7% | 9.5% | 46.3% | -29.7% | 4.3% | 19.2% | 11.7% | 20.3% | -25.4% | 47.8% | -10.7% | -- |
| OP Margin | -- | 7.4% | 10.1% | 12.4% | 15.2% | 15.3% | 10.1% | 15.6% | 15.3% | 13.8% | 12.8% | 10.7% | 14.5% | 10.8% | -7.9% |
| Net Margin | -- | 5.7% | 8.0% | 9.5% | 11.9% | 11.7% | 8.4% | 11.8% | 11.3% | 10.4% | 9.7% | 8.3% | 10.9% | 8.3% | 9.7% |
| Material Cost % | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Employee Cost % | 5.6% | 6.0% | 6.2% | 6.7% | 6.0% | 6.7% | 6.5% | 6.4% | 6.0% | 6.5% | 6.1% | 6.0% | 5.8% | 6.7% | 5.7% |
| P/S | 2.81 | 3.09 | 3.31 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 31.89 | 35.15 | 32.10 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 4.33 | 5.15 | 5.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Cancellation of Analyst/Institutional Investor Meet scheduled to be held on October 23, 2026
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Schedule of Analyst/Institutional Investors Meet(s) to be held in the month of November, 2026
Schedule of Analyst/Institutional Investor Meet to be held on October 23, 2026
Please find enclosed transcript of the earnings conference call with investor(s) and analyst(s) for the quarter and half-year ended September 30, 2026
Extract of Audited Financial Results of the Company for the quarter and half-year ended September 30, 2026 - Newspaper Publication
Please find enclosed communication sent to shareholders regarding TDS
Please find enclosed weblink of audio recording of earning conference call held on October 14, 2026.
The Board of Directors of the Company has approved declaration and payment of an interim dividend of Rs. 7/- per share for the financial year ended March 31, 2027.
We would like to inform you that Record date for the purpose of payment of interim dividend shall be Friday, October 23, 2026
Outcome of the Board Meeting held on Wednesday, October 14, 2026
Press Release and Investor Presentation on performance review of the Company for the quarter and half year ended September 30, 2026
Outcome of the Board Meeting held on Wednesday, October 14, 2026
Allotment of 4,009 equity shares on October 14, 2026
Update on Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Q2 & H1-FY2027 Earnings Call Pursuant to Regulation 30(6) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Q2 ....
Allotment of 32,526 equity shares on October 5, 2026
Update on Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclsoure Requirements) Regulations, 2015
Please find enclosed, Digital Day - Link for vedio presentation.
Please find enclosed Digital Day presentation.
Trading window closure for dealing in Securities of the Company
ICICI Lombard General Insurance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/10/2026 ,inter alia, to consider and approve Audited ....
Allotment of 6521 equity shares on September 22, 2026
Schedule of Digital Day Meet 2026 to be held on September 29, 2026.
Allotment of 5481 equity shares on September 15, 2026.
Please find enclosed copies of newspaper advertisement published regarding loss of share certificate
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Allotment of 4,212 equity shares on September 2, 2026
Update on Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Allotment of 71297 equity shares on August 24, 2026.
Schedule of Analyst/Institutional Investor Meet(s) to be held in the month of September, 2026
Allotment of 13,890 equity shares on August 12, 2026
Schedule of Analyst/Institutional Investor Meet - Change in Mode of Meeting for August 28, 2026
Schedule of Analyst/Institutional Investor Meet to be held on August 18, 2026
Update on Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper advertisement regarding transfer of Dividend and shares to IEPF
Communication sent to shareholders regarding transfer of equity shares to Investor Education and Protection Fund (IEPF)
Schedule of Analyst/Institutional Investor Meet(s) to be held in the month of August, 2026.
Allotment of 20,957 equity shares on July 23, 2026.
Extract of Audited Financial Results of the Company for the quarter ended June 30, 2026 - Newspaper Publication
Please find enclosed weblink of audio recording of earning conference call held on July 15, 2026.
Press Release and Investor Presentation on performance review of the Company for the quarter ended June 30, 2026
Outcome of the Board Meeting held on July 15, 2026
Outcome of the Board Meeting held on July 15, 2026
Update on litigation - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Allotment of 8,186 equity shares on July 14, 2026
Intimation regarding cessation of Mr. Ved Prakash Chaturvedi (DIN:00030839) as a Non-executive, Independent Director of the Company.
Intimation of Q1-FY2027 Earnings Call Pursuant to Regulation 30(6) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Q1-FY2027 ....
Allotment of 57,538 equity shares on July 3, 2026
The trading window for dealing in securities of the Company will remain closed for all Designated Persons and their immediate relatives
Annual Reports
16Credit Ratings
6Concalls
46Apr 2026
30 Apr 2026Jan 2026
31 Jan 2026Oct 2025
31 Oct 2025Oct 2025
31 Oct 2025Jul 2025
31 Jul 2025Apr 2025
30 Apr 2025Jan 2025
31 Jan 2025Oct 2024
31 Oct 2024Jul 2024
31 Jul 2024Apr 2024
30 Apr 2024Jan 2024
31 Jan 2024Oct 2023
31 Oct 2023Jul 2023
31 Jul 2023Apr 2023
30 Apr 2023Apr 2023
30 Apr 2023Apr 2023
30 Apr 2023Jan 2023
31 Jan 2023Nov 2022
30 Nov 2022Oct 2022
31 Oct 2022Jul 2022
31 Jul 2022Jul 2022
31 Jul 2022Apr 2022
30 Apr 2022Jan 2022
31 Jan 2022Oct 2021
31 Oct 2021Sep 2021
30 Sept 2021Jul 2021
31 Jul 2021May 2021
31 May 2021Apr 2021
30 Apr 2021Jan 2021
31 Jan 2021Dec 2020
31 Dec 2020Dec 2020
31 Dec 2020Nov 2020
30 Nov 2020Oct 2020
31 Oct 2020Sep 2020
30 Sept 2020Jul 2020
31 Jul 2020May 2020
31 May 2020Jan 2020
31 Jan 2020Oct 2019
31 Oct 2019Jul 2019
31 Jul 2019Apr 2019
30 Apr 2019Jan 2019
31 Jan 2019Oct 2018
31 Oct 2018Jan 2018
31 Jan 2018Nov 2017
30 Nov 2017Nov 2017
30 Nov 2017Apr 2015
30 Apr 2015Held by ETFs
32 ETFs hold icicigi · sorted by weight
Held by Mutual Funds
158 schemes hold icicigi · sorted by weight